Pfizer’s Crizotinib receives positive opinion for conditional marketing authorization from the CHMP
06:18 EDT 20 Jul 2012 | European Pharmaceutical Review
“The CHMP’s positive opinion brings us a step closer..."
Original Article: Pfizer’s Crizotinib receives positive opinion for conditional marketing authorization from the CHMP
More From BioPortfolio on "Pfizer’s Crizotinib receives positive opinion for conditional marketing authorization from the CHMP"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
